Search

Search Constraints

You searched for: Author/Creator Statland, Jeffrey M

Search Results

1. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial. Issue 3 (March 2023)

3. Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies. (21st February 2020)

4. Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis. Issue 1 (3rd December 2020)